Cargando…
The Mechanistic Basis for Noncompetitive Ibogaine Inhibition of Serotonin and Dopamine Transporters
Ibogaine, a hallucinogenic alkaloid proposed as a treatment for opiate withdrawal, has been shown to inhibit serotonin transporter (SERT) noncompetitively, in contrast to all other known inhibitors, which are competitive with substrate. Ibogaine binding to SERT increases accessibility in the permeat...
Autores principales: | Bulling, Simon, Schicker, Klaus, Zhang, Yuan-Wei, Steinkellner, Thomas, Stockner, Thomas, Gruber, Christian W., Boehm, Stefan, Freissmuth, Michael, Rudnick, Gary, Sitte, Harald H., Sandtner, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365767/ https://www.ncbi.nlm.nih.gov/pubmed/22451652 http://dx.doi.org/10.1074/jbc.M112.343681 |
Ejemplares similares
-
Unifying Concept of Serotonin Transporter-associated Currents
por: Schicker, Klaus, et al.
Publicado: (2012) -
Occupancy of the Zinc-binding Site by Transition Metals Decreases the Substrate Affinity of the Human Dopamine Transporter by an Allosteric Mechanism
por: Li, Yang, et al.
Publicado: (2017) -
Tropane-Based Ibogaine Analog Rescues Folding-Deficient
Serotonin and Dopamine Transporters
por: Bhat, Shreyas, et al.
Publicado: (2020) -
Electrogenic Binding of Intracellular Cations Defines a Kinetic Decision Point in the Transport Cycle of the Human Serotonin Transporter
por: Hasenhuetl, Peter S., et al.
Publicado: (2016) -
Handling of intracellular K(+) determines voltage dependence of plasmalemmal monoamine transporter function
por: Bhat, Shreyas, et al.
Publicado: (2021)